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1  | INTRODUCTION
Bacterial cross‐resistance can be defined as resistance to multiple 
distinct antimicrobial agents conferred by a single molecular mech‐
anism. It occurs when antimicrobials share a route of access to the 
cytoplasm, bind the same target or are involved in the same path‐
way leading to the inhibition of growth or cell death (Baker‐Austin, 
Wright, Stepanauskas, & McArthur, 2006). This phenomenon is 
best described in the context of shared resistance between differ‐
ent clinical antibiotic classes (Sanders, Sanders, Goering, & Werner, 
1984), between antibiotics and disinfectants, biocides or solvents 
(Chapman, 2003; Chuanchuen et al., 2001; Fernandes, Ferreira, & 
Cabral, 2003) and between antibiotics and heavy metals (Baker‐
Austin et al., 2006). An example of cross‐resistance is the efflux 
system AcrAB–TolC which confers resistance to multiple classes 
of antimicrobials but also to metals, dyes and detergents (Anes, 
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Abstract
Bacteria interact with a multitude of other organisms, many of which produce antimi‐
crobials. Selection for resistance to these antimicrobials has the potential to result in 
resistance to clinical antibiotics when active compounds target the same bacterial 
pathways. The possibility of such cross‐resistance between natural antimicrobials 
and antibiotics has to our knowledge received very little attention. The antimicrobial 
activity of extracts from seaweeds, known to be prolific producers of antimicrobials, 
is here tested against Staphylococcus aureus isolates with varied clinical antibiotic re‐
sistance profiles. An overall effect consistent with cross‐resistance is demonstrated, 
with multidrug‐resistant S. aureus strains being on average more resistant to seaweed 
extracts. This pattern could potentially indicate that evolution of resistance to anti‐
microbials in the natural environment could lead to resistance against clinical antibi‐
otics. However, patterns of antimicrobial activity of individual seaweed extracts vary 
considerably and include collateral sensitivity, where increased resistance to a par‐
ticular antibiotic is associated with decreased resistance to a particular seaweed ex‐
tract. Our correlation‐based methods allow the identification of antimicrobial 
extracts bearing most promise for downstream active compound identification and 
pharmacological testing.
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McCusker, Fanning, & Martins, 2015). It is increasingly realized that 
bacterial exposure to anthropogenic antimicrobials in wastewater, 
agricultural settings or the built environment, has the potential to 
co‐select for resistance to clinical antibiotics and significantly con‐
tribute to the rise of antibiotic‐resistant pathogens (Wellington et al., 
2013). However, the potential of the natural environment to co‐se‐
lect for antibiotic resistance has received little attention (Allen et al., 
2010). As the genetic mechanisms conferring antibiotic resistance 
are ancient and many of the selective forces that can promote the 
spread of these mechanisms are potentially nonanthropogenic, this 
is of concern.
One potential avenue of selection for antibiotic resistance in 
the natural environment is selection for resistance driven by antimi‐
crobial‐producing organisms. Virtually all organisms, from bacteria 
to humans, produce antimicrobial compounds (Raaijmakers, Vlami, 
& De Souza, 2002; Zasloff, 2002). The ubiquity of interactions be‐
tween bacteria and antimicrobial producers offers great potential 
for the molecular diversification of bacterial resistance mechanisms, 
a subset of which might also confer resistance to clinical antibiotics. 
To our knowledge, there have been no previous investigations into 
the level of cross‐resistance of natural antimicrobials with clinical 
antibiotics. This lack of data is problematic as environmental reser‐
voirs of resistant bacteria or resistance genes could make their way 
back into the clinic or community and cause hard‐to‐treat infections.
The opposite effect of cross‐resistance is collateral sensitivity, 
where pleiotropic effects cause resistance to natural antimicrobials 
to be negatively correlated with resistance to antibiotics (Pál, Papp, 
& Lázár, 2015). One example is the evolution of aminoglycoside 
resistance through mutations resulting in a reduction in the pro‐
ton‐motive force, leading to a diminished activity of efflux pumps 
involved in resistance to a range of other antibiotics classes (Lázár 
et al., 2013). Such trade‐offs between two antimicrobials can be ex‐
ploited for clinical use in the form of combination therapy (Pál et al., 
2015). Optimizing discovery strategies for novel antimicrobials that 
display collateral sensitivity with clinical antibiotics could be a prom‐
ising strategy to combat multidrug‐resistant bacterial pathogens.
We here use pathogenic Staphylococcus aureus isolates and sea‐
weeds as a model for cross‐resistance and collateral sensitivity be‐
tween clinical antibiotics and natural antimicrobials. S. aureus is an 
opportunistic pathogen, and strains resistant to multiple antibiotics 
(including methicillin [MRSA] [12]) are causing increased mortality 
and costs of care (De Kraker, Davey, & Grundmann, 2011; Macedo‐
Viñas et al., 2013; Rubio‐Terrés, Garau, Grau, & Martinez‐Martinez, 
2010). Seaweeds (or “macroalgae”) form a diverse and abundant 
component of coastal ecosystems. Seaweeds lack cell‐based im‐
mune responses but are continually exposed to a large variety of 
potentially harmful microorganisms present in seawater. It has 
therefore been hypothesized that they commonly exhibit antimicro‐
bial activity to prevent fouling and disease (Goecke, Labes, Wiese, 
& Imhoff, 2010; Plouguerne, Hellio, Deslandes, Véron, & Stiger‐
Pouvreau, 2008; Weinberger, 2007). A large number of studies have 
demonstrated that extracts of many seaweed species are able to 
kill or inhibit Gram‐positive and Gram‐negative bacteria, including 
nonmarine human pathogens such as S. aureus (e.g., Horikawa, Noro, 
& Kamei, 1999; Pierre et al., 2011).
We pair a large set of diverse S. aureus strains isolated from 
human infections with extensively characterized clinical antibiotic 
resistance spectra to a collection of seaweed extracts. We use quan‐
titative measures of susceptibility, allowing detailed correlation anal‐
yses on the efficacy of antimicrobial extracts. We first test whether 
multidrug‐resistant bacterial display greater on average levels of 
resistance to seaweed extracts. We next analyse patterns indica‐
tive of cross‐resistance and collateral sensitivity between individual 
extracts and clinical antibiotics. Our results both shed light on the 
potential of macroalgae to select for antibiotic resistance in the bac‐
teria that settle on them and have the potential to inform strategies 
of natural product discovery.
2  | MATERIAL AND METHODS
2.1 | Seaweed extracts
Seaweeds were collected along the southwest coast of Cornwall 
(UK). Intertidal species were collected at low tide, with subtidal spe‐
cies retrieved by scuba diving. Seaweeds were carefully inspected, 
and epiphytes and necrotic areas were removed, followed by rins‐
ing with ddH20. Washed samples were sealed in individual bags and 
stored at −20°C until extraction. Samples were lyophilized using a 
freeze drier (Scanvac, Labogene, Lynge, Denmark) and ground using 
a household spice grinder (James Martin ZX809X). The resulting 
powder was mixed with 60% methanol (5 g in 50 ml) and incubated 
for 2 hr at 40°C at 100 rpm. After extraction, samples were centri‐
fuged at 1,000 g for 15 min, after which the supernatant was evap‐
orated and resuspended to a final volume of 5 ml in a fume hood. 
Concentrated extract was aliquoted and stored at −80°C until fur‐
ther use.
2.2 | Bacterial strains
Twenty‐eight pathogenic Staphylococcus aureus isolates were ob‐
tained from the Royal Cornwall Hospital in Truro (UK). VITEK 2 AST 
(bioMérieux, Marcy‐l’Étoile, France) data detailing antibiotic suscep‐
tibility were provided for each strain after removing patient data. 
Individual colonies were picked and cultured in 5 ml LB broth (37°C, 
100 rpm) and stored as 20% glycerol freezer stocks at −80°C.
2.3 | Kirby‐Bauer disc diffusion assay
A Kirby‐Bauer disc diffusion assay (Bauer, Perry, & Kirby, 1959) 
was performed using overnight cultures (18 hr) diluted in broth to 
a turbidity equivalent to a McFarland standard (Andrews, 2013) of 
0.5 at 625 nm as measured by spectrophotometry (Bibby Scientific 
Limited, Staffordshire, UK). Four hundred micro litre of this dilu‐
tion was mixed with 30 ml of sterile Mueller‐Hinton agar (Oxoid, 
Basingstoke, UK) and poured into square plates (Gosselin, Borre, 
France). Whatman AA assay discs (Whatman International Limited, 
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Maidstone, UK), soaked in seaweed extract for 24 hr, were dried in 
a laminar flow hood for 15 min. Positive control (imipenem, 4 mg/L) 
and negative control (60% methanol) discs were soaked and dried 
in the same way. Dry discs were placed on the agar using sterile 
tweezers (14 seaweed extract discs and two controls per plate, all 
combinations were plated in duplicate). Plates were incubated at 
37°C. After 18 hr, zones of inhibition (areas with no visible bacte‐
rial growth) were measured for each disc. Inhibition zone sizes were 
recorded as total diameter minus size of the diffusion disc (5 mm).
2.4 | Minimum inhibitory concentration
Seaweed extracts (200 µl) were evaporated overnight in the first 
column of a 96‐well plate (Starlab Limited, Milton Keynes, UK). A 
twofold dilution range of each extract (200 µl volume) was made in 
nine columns in LB broth, with the remaining two columns used as 
positive and negative controls. Diluted bacterial inoculum was added 
to a final concentration of 5 × 105 CFU/ml. 10 μl alamar blue dye 
(Thermo Fisher Scientific Incorporated, Waltham, USA) was added 
as an indicator of bacterial respiration (growth). Plates were briefly 
agitated and incubated at 37°C for 18 hr. Antimicrobial susceptibil‐
ity to Tetracycline, Oxacillin, Cefotaxime, Gentamicin, Rifampicin 
and Erythromycin (Sigma‐Aldrich, Steinheim, Germany) was tested 
for a subset of strains. Stock solutions (10 mg/ml) were prepared 
in ddH2O and filter sterilized. A broth microdilution assay was per‐
formed in a 96‐well plate as described above, using antibiotic con‐
centrations from 0.1 to 100 mg/L.
2.5 | Genome sequencing, bioinformatics and 
phylogenetic analyses
A phenol:chloroform:isoamyl alcohol DNA isolation protocol 
modified from Sambrook and Russel (Sambrook, 2006) was used 
to obtain genomic DNA. DNA quality was visually assessed on a 
1% agarose gel, and DNA quality was measured using Qubit fluo‐
rometer (Life Technologies). DNA was dissolved in Elution Buffer 
(10 mM TRIS, pH8) and sent on dry ice to the University of Exeter 
Sequencing Facility. Sequencing libraries were run on a Hiseq 
2,500 in rapid run mode (250 base pair paired‐end reads) yielding 
between 1.3 and 6 million reads per sample. Sequencing data were 
trimmed to remove sequencing adaptors and low‐quality terminal 
ends (<Q20) using fastq‐mcf v1.1.2‐537 (Aronesty, 2011). Reads 
were assembled using SPAdes 3.11.0 (Bankevich et al., 2012) 
and assessed using QUAST (Gurevich, Saveliev, Vyahhi, & Tesler, 
2013). Small contigs (<500 base pairs) were removed. Short reads 
were mapped to the reference genome H0 5096 0412 (EMRSA 
15) using SMALT on default settings and a mean insert size 
of 300 bp (http://www.sanger.ac.uk/resources/software/smalt/). 
Reads containing insertions or deletions (indels) were realigned 
using the Genome Analysis Toolkit's IndelRealigner (https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC2928508/). Single nucleotide 
polymorphisms (SNPs) were called using SAMtools 0.1.18 (H. Li et 
al., 2009). Variants were filtered using in‐house scripts to include 
only SNPs with >4x read depth per base (>2 per strand), >75% 
support for an alternative variant, mapping quality >30 and a site 
allele frequency of the alternative allele of >0.95. Samples were 
sequence typed using ARIBA from the pubMLST databases ac‐
cessed on 26 January 2017 (Hunt et al., 2017). A maximum‐likeli‐
hood phylogenetic tree was reconstructed for core genomes using 
RAxML (Stamatakis, 2014). Consensus sequences generated by 
the variant calling pipeline were passed to RAxML under a gen‐
eral time‐reversible (GTR) model of nucleotide substitution with 
a GAMMA rate of site heterogeneity. A rapid bootstrap analysis 
(100 bootstraps) and search for best‐scoring ML tree were per‐
formed in a single program run.
2.6 | Statistical analyses
Test, correlation covariance and ANOVA were performed in R (ver‐
sion 0.98.1103, R Core Team, 2013; Team, 2015). Dedicated pack‐
ages corrplot and survival were used for survival analysis (Therneau 
& Lumley, 2015; Wei & Wei, 2015). The packages gplots (Warnes et 
al., 2013) and ggplot2 (Wickham, 2009) and lattice (Sarkar & Sarkar, 
2015) were used for graphics. To categorize the extracts into those 
with nearly constant effect and others with a more variable ef‐
fect, the k‐means algorithm (Bishop, 2006) was used on inhibition 
zone standard deviations with two classes and the default settings 
in MATLAB (Release, 2012). To maximize power while accounting 
for multiple hypothesis testing, a standard permutation test (Gao, 
Becker, Becker, Starmer, & Province, 2010) was used to identify indi‐
vidual extracts in the more variable class with significant association 
between the level of clinical (VITEK) resistance and the halo sizes. 
Correlations between the clinical resistance and the average inhibi‐
tion zone size from replicate measurements for each extract were 
calculated and tested for significance using 100,000 random permu‐
tations of clinical resistance values. Trees and figures were visualized 
using the R package ggtree (Yu, Smith, Zhu, Guan, & Lam, 2017).
3  | RESULTS
3.1 | Resistance to seaweed extracts as a function 
of multidrug resistance
A total of 48 species of macroalgae were collected from intertidal 
and shallow subtidal waters in Cornwall, UK (Table S1) and processed 
into methanolic extracts of standardized dry weight concentration. 
Extracts were used in a disc diffusion assay (Figure S1) to challenge 
28 clinical S. aureus strains, each with a unique clinical antibiotic sus‐
ceptibility profile (Table S2). Beta‐lactam resistance was observed 
at high frequency within the collection: 26 isolates were resistant 
to benzylpenicillin. Fourteen isolates were methicillin resistant, and 
all of these MRSA isolates were also resistant to oxacillin and broad 
spectrum cefoxitin. Intermittent resistance to fusidic acid, clindamy‐
cin, erythromycin and tetracycline was observed (Table S2).
27/48 (56%) of extracts showed activity against at least one S. 
aureus strain, as indicated by a clear zone of growth inhibition. A total 
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of 17 extracts inhibited all 28 bacterial strains, whereas ten extracts 
showed inhibition against a subset of strains (Table S1). Plotting 
the number of clinical antibiotics against the number of seaweed 
extracts each strain was resistant to reveals a significant positive 
correlation (Figure 1; R2 = 0.21, p < 0.01), indicating that on aver‐
age, antimicrobials isolated from natural sources are least effective 
against the most problematic multidrug‐resistant strains. In addition 
to scoring presence or absence of inhibition zones, the effect of indi‐
vidual seaweed extracts was analysed by quantifying inhibition zone 
sizes. Inhibition zone size is significantly negatively correlated with 
the Minimum Inhibitory Concentration (minimum inhibitory concen‐
tration [MIC], the lowest concentration at which bacterial growth is 
inhibited) based on pairing 27 active extracts with the strain most 
sensitive to clinical antibiotics (R2 = 0.21, p < 0.01; strain SA2934, 
Figure 2). Strains resistant to a greater number of clinical antibiot‐
ics showed a tendency to display a smaller total inhibition zone size 
(sum of inhibition zone sizes of the 27 seaweed extracts) (R2 = 0.08, 
p = 0.07; Figure 3), consistent with the data in Figure 1.
3.2 | Resistance to individual seaweed extracts as a 
function of multidrug resistance
In order to identify individual extracts that showed a significantly 
positive or negative relationship with overall clinical resistance, 
a k‐means algorithm was used on inhibition zone size standard de‐
viations to divide extract in a high and a low variance class. The ma‐
jority of extracts (21) show low variation in activity across the panel 
(Figure 4). Next, a permutation test was used on the seven high vari‐
ance species (Chaetomorpha melagonium, Ulva lactuca, Cladophora 
rupestris, Ceramium rubrum, Spyridia griffithsiana, Corallina officinalis 
and Plumaria plumosa) to test whether their activity was signifi‐
cantly correlated with clinical resistance as determined by VITEK. 
Three extracts displayed moderately strong negative association 
with clinical resistance, with halo size decreasing with increasing 
F I G U R E  1   Correlation between clinical resistance (sum of 
22 antibiotics assayed using VITEK technology) and seaweed 
resistance (sum of 27 methanolic extracts) for 28 S. aureus isolates 
(R2 = 0.21, p < 0.01).
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F I G U R E  2   Correlation between dilution factor and inhibition 
zone size for 27 extracts assayed on strain SA2934 (R2 = 0.21, 
p < 0.01). Dilution factor is inversely proportional to Minimal 
Inhibitory Concentration (MIC).
F I G U R E  3   Correlation between resistance against clinical 
antibiotics (assayed using VITEK technology) and seaweed 
resistance as quantified by the sum of inhibition zone sizes of 
the 27 seaweed extracts able to inhibit all 28 S. aureus isolates 
(R2 = 0.08, p < 0.07).
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clinical resistance, of which two were highly significant (C. rupestris: 
r = −0.487, p = 0.00423; C. rubrum: r = −0.463, p = 0.00681) and one 
borderline nonsignificant (U. lactuca: r = −0.306, p = 0.0567). No 
extracts were found to have a significantly positive association be‐
tween inhibition size and clinical resistance.
3.3 | Cross‐resistance and collateral sensitivity 
patterns between individual seaweed extracts and 
antibiotics
A more detailed analysis based on extract inhibition zone sizes for 
27 seaweed extracts and MICs for 14 different antibiotics was per‐
formed using Pearson correlation coefficients (Figure 5). This analy‐
sis shows that the activities of some seaweeds across the S. aureus 
panel are similar, suggesting that they produce similar antimicrobial 
compounds. In some cases, seaweed extracts show activity pat‐
terns similar to those of antibiotics, for example, Cystoseira baccata, 
Cystoseira tamariscifolia and oxacillin (Figure 5). However, the oppo‐
site pattern of cross‐resistance, where the activity of antibiotics is 
negatively correlated with the activity of seaweed extracts, also oc‐
curs, for example, benzylpenicillin and Jania rubens or ciprofloxacin 
and C. melagonium, C. rubrum and Ascophyllum nodosum (Figure 5).
3.4 | Antimicrobial activity as a function of seaweed 
relatedness
To test whether closely related seaweeds species had similar an‐
timicrobial activity, we focused on the only genus represented by 
three species: Cystoseira (C. tamariscifolia, C. baccata and C. nodicau-
lis). Two of the three species were found to have highly similar ef‐
fects on the panel of 28 S. aureus strains whereas a third species 
F I G U R E  4   Box‐plots of inhibition zone size standard deviations 
for a high and low variance seaweed antimicrobial activity group 
created by the k‐means algorithm with default settings
F I G U R E  5   Pearson correlation 
coefficients between seaweed extract 
inhibition zone sizes and clinical antibiotic 
MICs assayed using VITEK technology 
generated on a test panel of 28 S. aureus 
isolates. Colour‐coded values range from 
−1 = perfect negative correlation (red) 
to 1 = perfect positive correlation (blue); 
the size of the data points co‐varies with 
colour intensity
     |  883COLCLOUGH et aL.
had a noticeably different overall effect, as highlighted by a heatmap 
(Figure 6a). Differential inhibition could in theory be due the pro‐
duction of different active compounds (i.e., qualitative differences) 
or due to differences in concentration of compounds (i.e., quantita‐
tive differences) between extracts. By plotting inhibition zone sizes 
on all 28 S. aureus strains for the three different pairwise extract 
combinations (Figure 6b), it is possible to distinguish between these 
two scenarios. A specific extract can be expected to show the same 
qualitative effect on the panel of bacteria regardless of its concen‐
tration (i.e., a more diluted extract will show proportionally smaller 
inhibition zones). That there is no significant correlation between the 
outlier species C. nodicaulis and the two other species indicates that 
its extract is qualitatively different (Figure 6b).
A previous study demonstrated that of these three Cystoseira spe‐
cies, C. tamariscifolia was the out‐group on the basis of the ITS2 se‐
quence and two physicochemical methods (Jégou, Culioli, Kervarec, 
Simon, & Stiger‐Pouvreau, 2010). A disc diffusion assay where the 
three Cystoseira extracts were tested against three Gram‐negative 
species confirmed the out‐group position of C. tamariscifolia (Figure 
S2). Together, these findings demonstrate that genetic divergence, 
metabolomic divergence and antagonistic activity on other bacterial 
types are not reliable indicators of antimicrobial activity. Differences 
in antagonistic activity were observed for two Fucus species, two 
Ulva species and two Ceramium species, further supporting the ob‐
servation that antimicrobial activity can vary within seaweed genera 
(data not shown).
3.5 | Genomic context of seaweed 
extract resistance
We obtained 26 high‐quality S. aureus genomic sequences, which 
revealed that a large proportion of known clinical S. aureus diversity 
was captured, with common sequence types (STs) from nosocomial 
infections (ST22; Holden et al., 2013) (ST250; Enright et al., 2002), 
community‐associated lineages (ST1; Earls et al., 2017), (ST59; Qu 
et al., 2014) and some strains more commonly associated with ag‐
ricultural environments (ST5; Hau et al., 2018) (ST1245/CC130; 
Bortolami et al., 2017) represented within the collection. The antibi‐
otic resistance profiles across the phylogenetic diversity of this S. au-
reus collection indicated a range of high and low antibiotic resistance 
isolates, in keeping with the broad population diversity captured 
within the collection (Fig. S3). Visualization of the susceptibility of 
S. aureus isolates to seaweed extracts alongside the phylogenetic 
tree of the S. aureus sample collection indicated limited genotype–
phenotype clustering with large variation between seaweed extract 
treatments (Figure 7, red = resistant, green = susceptible).
4  | DISCUSSION
We here, to our knowledge for the first time, demonstrate that bac‐
terial resistance to clinical antibiotics is positively correlated with 
resistance to natural antimicrobials. A subset of seaweed extracts 
showed antimicrobial activity patterns similar to those of clinical 
antibiotics, a pattern that is consistent with cross‐resistance, where 
active compounds are structurally similar and/or target the same 
bacterial pathway (Baker‐Austin et al., 2006). The potential of cross‐
resistance between natural antimicrobials and clinical antibiotics has 
important implications for human health. Recent, careful experimen‐
tation has demonstrated that ecologically relevant concentrations 
of secondary metabolites as exuded in the seaweed‐water bound‐
ary layer can select which bacteria can successfully settle (Lachnit, 
Fischer, Künzel, Baines, & Harder, 2013; Lachnit, Wahl, & Harder, 
2009). Taken together, these findings suggest that seaweeds can se‐
lect for colonizing bacteria that are resistant to their metabolites and 
that it is possible these same bacteria could also be more resistant 
to clinical antibiotics.
Many human pathogens can be found in environmental reser‐
voirs, with S. aureus able to survive for significant periods in coastal 
waters (Levin‐Edens, Bonilla, Meschke, & Roberts, 2011; Tolba et 
al., 2008). Although the potential for prolonged (co‐)evolution of 
S. aureus in the marine environment might be limited, we note that 
humans could be exposed to a whole range of human pathogens, 
increasing the scope for resistance evolution and exposure. For 
F I G U R E  6   Differences in anti‐S. aureus 
activity between three Cystoseira species: 
C. tamariscifolia (CT), C. baccata (CB) and 
C. nodicaulis (CN) based on the average of 
two independent replicates. (a) Heatmap 
showing inhibition zone size (yellow: small, 
red: large) for each of the three extracts 
on 28 S. aureus isolates clearly demarcates 
the CN extract as having differential 
activity. (b) A correlation matrix plotting 
inhibition zone sizes for pairs of extracts 
on the S. aureus panel
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instance, it has been estimated that there are over six million expo‐
sure events to cephalosporin‐resistant E. coli through recreational 
use of coastal bathing water in England and Wales alone (Leonard, 
Zhang, Balfour, Garside, & Gaze, 2015). Increased persistence of 
multidrug‐resistant pathogens settling on seaweeds in polluted 
coastal waters and possible in situ antibiotic resistance evolution of 
pathogens via mutation or the lateral transfer of resistance genes 
from bacteria native to seaweeds thus warrants further investiga‐
tion. We also note that the potential for any “biotic co‐selection” 
extends beyond seaweeds and the wider marine environment and 
could potentially be mediated by different organisms and in terres‐
trial habitats.
Rather than using bacterial antibiotic‐resistant mutants gener‐
ated through mutational processes in short‐term evolution exper‐
iments (e.g., Imamovic & Sommer, 2013), we used a genomically 
diverse set of pathogenic isolates more representative of resistance 
evolution to test for patterns of cross‐resistance. The antibiotic re‐
sistance profiles indicated a range of high and low resistance iso‐
lates, in keeping with the broad population diversity captured within 
the collection (Figure S3). No clear congruence could be observed 
between genomic relatedness and seaweed extract resistance. 
Some seaweed extracts showed generally low or high antimicrobial 
activity, but the extracts that showed variation in activity often did 
so across the entire phylogeny (e.g., see the activity of C. melago-
nium, C. officinalis and Cladostephus spongiosus in Figure 6). The un‐
coupling of phylogenetic relatedness and resistance patterns could 
have arisen due to a variety of reasons. The chemically diverse na‐
ture of extracts could mean a wide range of mechanisms underlies 
resistance phenotypes, from more targeted antibiotic‐like activity 
to unspecific biocidal activity. Lateral gene transfer is expected to 
unlink the carriage of genes involved in resistance and overall ge‐
nomic relatedness. However, the fact that resistance is observed 
even within a clonal complex (e.g., ST22, Figure 6) makes divergence 
in resistance due to single point mutations likely as well.
Two extracts showed significantly less activity on strains that 
were more antibiotic resistant. The activity of other extracts 
showed relatively low variation in inhibition across the test panel, 
which in part could be caused by antimicrobial resistance mecha‐
nisms distinct from clinical resistance mechanisms. For instance, 
A. armata showed a particularly low level of variation in activity 
across the test panel; anti‐S. aureus activity of this species has been 
shown to be due to the production of bromoform and dibromoace‐
tic acid (Paul, de Nys, & Steinberg, 2006). Brominated compounds 
act as mutagens (DeMarini, Perry, & Shelton, 1994; Kargalioglu, 
McMillan, Minear, & Plewa, 2002) which are not expected to act 
differently in strains with different antibiotic resistance. In a more 
F I G U R E  7   A maximum‐likelihood phylogenetic tree based on whole genome sequence data of 27 S. aureus genomes used in this 
study mapped to EMRSA15 reference genome HO 5,096 0,412 (not included in the tree) (2,832,299 bp). The panel on the right indicates 
susceptibility to 25 seaweed extracts, quantified by zone of inhibition (red = resistant, no inhibition; green = susceptible, high inhibition). 
Ceramium sp., and A. armata were excluded to aid visualization as they produced extremely high inhibition on the majority of the isolates. 
White cells in the figure indicate missing data. The phylogenetic tree was generated using a GTR model of nucleotide substitution and a 
GAMMA model of rate heterogeneity in RaxML
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direct comparison based on individual antibiotics and extracts, di‐
verse patterns of cross‐resistance and collateral sensitivity could be 
observed, suggesting a wide diversity in modes of action and re‐
sistance mechanisms. Collateral sensitivity was observed between 
seaweed extracts and a range of antibiotics, including β‐lactams, 
fluoroquinolones and lincosamides.
Humankind has resorted to natural products to treat infec‐
tions throughout history (Harrison et al., 2015), and the majority 
of drugs, including antibiotics, are natural products or have been 
derived from natural products (Butler & Buss, 2006; J. W.‐H. Li 
& Vederas, 2009). Decreases in profitability and biotechnological 
advances have meant that the search for novel pharmaceuticals 
has increasingly been led by high‐throughput screening of syn‐
thetic libraries (Clardy, Fischbach, & Walsh, 2006; J. W.‐H. Li & 
Vederas, 2009). Although modifications of existing structures with 
promising activity are relatively easy to generate and screen, con‐
cerns have been raised about the efficiency of this approach, as 
truly novel modes of actions are unlikely to be discovered (Chopra, 
2012). In contrast, natural products represent a vastly richer bio‐
chemical diversity, which moreover is based on an evolutionary 
history that has optimized physiological function through natural 
selection (Clardy & Walsh, 2004). Considering that only a single 
bacterial target species was assayed, the prevalence and diversity 
of antimicrobial activity of seaweed extracts confirm the promise 
that natural antimicrobials hold.
We hope that correlational analyses such as employed here can 
be used to facilitate identification of novel extracts bearing promise 
for costly and time‐intensive downstream active compound identifi‐
cation and pharmacological testing. More generally, we contend that 
multidisciplinary approaches combining insights from microbiology, 
evolutionary ecology and ideally biochemistry are necessary to bet‐
ter understand both the potential of novel antimicrobials and the 
threats of antimicrobial resistance in the environment.
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